As of November 6, 2026, Wave Life Sciences, Inc. is a publicly traded company (Nasdaq: WVE). The largest holder reporting an active stake on Schedule 13D is RA Capital, at 16.8%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include BlackRock (6.8%) (Schedule 13D/A, August 11, 2026).
Is this your company?
About to sign with, pay or invest in Wave Life Sciences, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Wave Life Sciences, Inc. a real, registered company?
- Wave Life Sciences, Inc. files with the SEC under CIK 1631574 (its SEC filings).
- Its shares are listed under the ticker WVE on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Cambridge, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Wave Life Sciences, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Wave Life Sciences, Inc.'s owners and officers?
Wave Life Sciences, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-27 | Blackrock, Inc. | 6.8% |
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 0% |
| Schedule 13D/A, 2026-08-11 | Ra Capital Management, L.P. | 16.8% |
| Schedule 13G/A, 2026-05-13 | Adage Capital Management, L.P. | 0.53% |
| Schedule 13G/A, 2026-05-06 | Fmr LLC | 2.8% |
| Schedule 13D/A, 2026-04-17 | Ra Capital Management, L.P. | 17.1% |
| Schedule 13D/A, 2026-03-30 | Ra Capital Management, L.P. | 17.5% |
| Schedule 13G/A, 2026-02-12 | Adage Capital Management, L.P. | 5.35% |
| Schedule 13G, 2026-02-05 | Fmr LLC | 8.5% |
| Schedule 13D/A, 2025-12-15 | Ra Capital Management, L.P. | 13.4% |
| Schedule 13D/A, 2025-11-13 | Ra Capital Management, L.P. | 14.6% |
| Schedule 13G/A, 2025-08-12 | Adage Capital Management, L.P. | 9.65% |
Questions about who owns Wave Life Sciences, Inc.
Who owns Wave Life Sciences, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Wave Life Sciences, Inc.: Ra Capital Management, L.P. (16.8%, Schedule 13D/A, filed 2026-08-11) and Blackrock, Inc. (6.8%, Schedule 13G, filed 2026-10-27).
Who are the largest shareholders of Wave Life Sciences, Inc.?
By the share each holder's latest filing reports, the largest holders of Wave Life Sciences, Inc. on this page are Ra Capital Management, L.P. (16.8%) and Blackrock, Inc. (6.8%).
When did Ra Capital Management, L.P. buy into Wave Life Sciences, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Ra Capital Management, L.P. on this page is the Schedule 13D/A, filed 2025-11-13, reporting 14.6%; its latest, Schedule 13D/A filed 2026-08-11, reports 16.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Wave Life Sciences, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Wave Life Sciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Wave Life Sciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Wave Life Sciences, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- GSK plc, a 10% owner: 18,245,691 shares (9.3% of shares outstanding), held indirectly through By Corporation (Form 4, 2025-12-15).
- , a director: 9,637,187 shares (4.9% of shares outstanding), 30,779 held directly and 9,606,408 indirectly (Form 4, 2026-10-07).
- Chandra Vargeese: 408,246 shares (0.21% of shares outstanding) (Form 4, 2026-02-11).
- , a director: 275,917 shares (0.14% of shares outstanding), 200,917 held directly and 75,000 indirectly (Form 4, 2026-10-07).
- , the chief executive and president: 275,520 shares (0.14% of shares outstanding) (Form 4, 2026-02-11).
Shares outstanding: 197,228,968 as of 2026-10-21, from the company's latest SEC cover page.
How much has Wave Life Sciences, Inc. raised?
No fundraising or offering filing from Wave Life Sciences, Inc. is on file with us.
Keep reading
More on Wave Life Sciences, Inc. and the records around it.
Wave Life Sciences, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- RA Capital Management, L.P. also filed stake reports on 100 other companies: Climb Bio, Inc. (Nov 2026), Bambusa Therapeutics, Inc. (Nov 2026), SOLID BIOSCIENCES INC. (Nov 2026)
- Adage Capital Management, L.P. also filed stake reports on 136 other companies: ACP Holdings Acquisition Corp. (Aug 2026), AmperCap Acquisition Company (Aug 2026), Aura Biosciences, Inc. (Aug 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/wave-life-sciences